InspireMD (FRA:II2) Short-Term Capital Lease Obligation : €0.51 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is InspireMD Short-Term Capital Lease Obligation?

InspireMD's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.51 Mil.

InspireMD's quarterly Short-Term Capital Lease Obligation increased from Jun. 2023 (€0.39 Mil) to Sep. 2023 (€0.47 Mil) and increased from Sep. 2023 (€0.47 Mil) to Dec. 2023 (€0.51 Mil).

InspireMD's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (€0.37 Mil) to Dec. 2022 (€0.40 Mil) and increased from Dec. 2022 (€0.40 Mil) to Dec. 2023 (€0.51 Mil).

InspireMD Short-Term Capital Lease Obligation Historical Data

The historical data trend for InspireMD's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InspireMD Short-Term Capital Lease Obligation Chart

InspireMD Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.33

0.37

0.40

0.51

InspireMD Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.40	0.39	0.39	0.47	0.51

InspireMD Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

InspireMD Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of InspireMD's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

InspireMD (FRA:II2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InspireMD Inc (FRA:II2) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

NSPR:USA

Address

4 Menorat Hamaor Street, Tel Aviv, ISR, 6744832

Website

https://www.inspiremd.com

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.

InspireMD (FRA:II2) Headlines

No Headlines